| A Phase I Study of the Safety and Pharmacokinetics of Recombinant Human CD4 Immunoglobulin (rCd4-IgG) Administered by Intravenous Bolus in Patients With AIDS and AIDS Related Complex (NCT00000675) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Valacyclovir Hydrochloride in the Prevention of Life-Threatening Cytomegalovirus Disease in HIV-Infected Patients (NCT00001038) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Clinical Trial to Evaluate: Part A. The Safety of MTP-PE/MF59 Adjuvant Emulsion. Part B. The Safety and Immunogenicity of Env 2-3, a Yeast Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 (NCT00000972) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Two-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) Infection (NCT00000955) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Blood Vessel Function in HIV-Infected Patients Taking Anti-HIV Drugs (NCT00050908) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women (NCT00017797) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effectiveness of Three Drug Combinations in HIV-Infected Patients Who Have Taken Zidovudine for More Than 12 Weeks (NCT00001063) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effectiveness of Giving an HIV Vaccine (Remune) to HIV-Positive Patients Receiving an Anti-HIV Drug Combination (NCT00005758) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Nitazoxanide for the Treatment of Chronic Diarrhea in HIV Infected Children (NCT00055107) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV vCP300 and HIV-1 SF-2 rgp120 in HIV-1 Uninfected Adult Volunteers (NCT00001072) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS (NCT00001047) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open Trial of Zidovudine (AZT) Treatment of the AIDS Dementia Complex in Patients With AIDS or Low CD4+ Lymphocyte Counts (NCT00000709) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Open-Label, Pilot Study to Evaluate the Development of Resistance to Nevirapine (BI-RG-587) in HIV-Infected Patients With CD4 Cell Count >= 500/mm3 (NCT00000747) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of a Recombinant Vaccinia-HIV Envelope Vaccine (HIVAC-1e) in Combination With a Panel of Subunit Recombinant HIV Envelope Vaccines in Vaccinia-Naive Individuals (NCT00001026) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Decreased Mental Function Associated With HIV (NCT00027040) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3 (NCT00000859) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II Double-Blind Study of Delavirdine Mesylate ( U-90152 ) in Combination With Zidovudine ( AZT ) and/or Didanosine ( ddI ) Versus AZT and ddI Combination Therapy (NCT00000803) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat (NCT00009555) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs (NCT00006290) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Peer Education to Prevent HIV Transmission Among Injection Drug Users and Their HIV Risk Contacts (NCT00038688) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Use of Cidofovir (an Experimental Drug) for the Treatment of Progressive Multifocal Leukoencephalopathy (PML) in AIDS Patients (NCT00000945) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis (NCT00000698) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Human Immune Responses Smallpox (NCT00068198) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Randomized Comparative Study of Fluconazole Versus Clotrimazole Troches in the Prevention of Serious Fungal Infection in Patients With AIDS or Advanced AIDS-Related Complex. (A Nested Study of ACTG 081) (NCT00000676) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Zidovudine Plus Acyclovir in HIV-Infected Patients (NCT00001010) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body (NCT00029341) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection (NCT00000789) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Abacavir Plus Indinavir Sulfate Plus Efavirenz in HIV-Infected Patients (NCT00001086) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients (NCT00001039) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| ALVAC-HIV vCP1452 Alone and Combined With MN rgp120 (NCT00011037) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly (NCT00001129) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effect of Interleukin-2 on HIV Treatment Interruption (NCT00015704) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Study of Safety and Pharmacokinetics of Nevirapine in HIV-1 Infected Pregnant Women and Neonates Born to HIV-1 Infected Mothers (NCT00000808) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants (NCT00000960) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC) (NCT00000659) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Effect of Nandrolone Decanoate in Women With HIV-Associated Weight Loss (NCT00000854) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex (NCT00000672) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effectiveness of Ritonavir Plus Zidovudine Plus Lamivudine in HIV-Infected Patients (NCT00001075) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Zidovudine in HIV-Infected Patients With Kidney Problems (NCT00000685) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Daily Tenofovir DF to Prevent HIV Infection Among Sex Workers in Cambodia (NCT00078182) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Safety and Tolerance of Nelfinavir (NFV) Given With Zidovudine (ZDV) and Lamivudine (3TC) in HIV-Positive Pregnant Women and Their Infants (NCT00000887) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Treatment IND for Retrovir Brand Zidovudine (AZT) Therapy of Pediatric Patients With HIV Disease (NCT00000662) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies (NCT00000942) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Giving Isotretinoin to HIV-Infected Women to Treat Cervical Tumors (NCT00001073) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized, Double Blind, Comparative Study of Dideoxycytidine (ddC) Alone or ddC/AZT Combination Versus Zidovudine (ZDV) Alone in Patients With HIV Infection Who Have Received Prior ZDV Therapy (NCT00000651) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Hormone Replacement Therapy and Anti-HIV Drugs in HIV-Infected, Postmenopausal Women (NCT00044837) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effect of Stomach Acid on Foscarnet (NCT00000964) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I, Dose-Escalating Safety and Tolerance Study of sCD4-PE40 in HIV-Infected Persons (NCT00000743) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients (NCT00001070) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Computer-Assisted Adherence Program for Patients Taking Anti-HIV Drugs (NCT00051766) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides (NCT00000802) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Withdrawal of Antifungal Treatment for Histoplasmosis in Patients After Improved Immune Response to Anti-HIV Drugs (NCT00006316) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection (NCT00000790) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT) (NCT00000727) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection (NCT00000666) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Placebo-Controlled, Phase I Clinical Trial to Evaluate the Safety and Immunogenicity of Recombinant Envelope Proteins of HIV-1 gp160 and gp120 in Children >= 1 Month Old With Asymptomatic HIV Infection (NCT00000762) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Two Different Formulations of an HIV Vaccine in Infants Born to HIV-Infected Women (NCT00000809) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood (NCT00000941) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I, Multicenter, Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination Schedules (NCT00001037) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Trivalent rHA Dose Escalation Study in Elderly Subjects (NCT00170443) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Valacyclovir HCl in the Treatment of Herpes Simplex or Varicella/Zoster Infections in HIV-1 Infected Children (NCT00001054) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Compare Two Different Anti-HIV Drug Regimens (NCT00000924) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients (NCT00000863) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Patients Who Recently Have Been Infected With HIV (NCT00006415) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome (NCT00001123) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| CS DNA MVA Trial in Mampong, Ghana (NCT00377494) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effects of BufferGel and PRO 2000/5 Gel in Men (NCT00016536) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effectiveness of Human Antibodies in Influencing an AIDS-Like Disease in Monkeys (NCT00031109) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults (NCT00096850) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox-gp160 MN (ALVAC vCP125, HIV-1 gp160 MN) in HIV-1 Uninfected Adult Volunteers (NCT00000813) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Open-Labelled Trial of Intravitreal Ganciclovir Salvage Therapy for AIDS Patients With Active CMV Retinitis Who Are Intolerant of Systemic Therapy (NCT00000673) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection (NCT00000638) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Two Drugs, Cidofovir and Ganciclovir, in Treating Patients With AIDS Who Have CMV Retinitis (NCT00000894) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Carotid Artery Thickness in HIV Infected and Uninfected Adults (NCT00007319) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Evaluate the Safety and Effectiveness of HIV-1 LAI gp120 (an HIV Vaccine) Given With or Without HIV-1 MN rgp120 (Another HIV Vaccine) to HIV-Negative Volunteers (NCT00000868) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Dexamethasone in Cryptococcal Meningitis (NCT00000776) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Comparison of Liposomal Doxorubicin Used Alone or in Combination With Bleomycin Plus Vincristine in the Treatment of Kaposi's Sarcoma in Patients With AIDS (NCT00001059) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Comparative Blinded Trial of Several HIV-1 Derived Immunogens in Infected Individuals With >= 500 CD4 Cells/mm3 (NCT00000779) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effects of Anti-HIV Drugs on the HIV Virus in HIV-Infected Patients (NCT00006442) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease. (NCT00000856) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Study and Treatment of Post Lyme Disease (STOP-LD) (NCT00000937) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Anti-HIV Activity and Safety of 3 Different Doses of Mifepristone in HIV Infected People (NCT00099645) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Identifying Emergency Room Patients Who Have Recently Been Infected With HIV (NCT00001130) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children (NCT00000952) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women (NCT01490671) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Pyrimethamine in the Treatment of Infection by a Certain Parasite in HIV-Positive Patients (NCT00000973) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Three Anti-HIV Drug Combinations in Patients Who Have Taken Amprenavir (NCT00001095) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Evaluating the Safety and Immune Response to Three Different Prime-Boost HIV Vaccine Regimens in Healthy, HIV-Uninfected Adults (NCT01970449) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| An Assessment of the In Vivo Biological Effects of Diethyldithiocarbamate (DTC) in HIV-Infected Patients (NCT00000650) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Doxorubicin in the Treatment of AIDS-Related Kaposi's Sarcoma (NCT00000996) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People (NCT00028366) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites (NCT00000826) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Zidovudine in the Prevention of HIV Infection in Individuals Exposed to the Virus (NCT00000993) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex (NCT00001004) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients (NCT00000860) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I Trial of Recombinant Human Granulocyte-Macrophage Colony Stimulating Factor (rHuGM-CSF), Recombinant Alpha Interferon and Azidothymidine (AZT) in AIDS-Associated Kaposi's Sarcoma (NCT00000694) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Foscarnet in the Treatment of HIV Infection in Patients Who Have Taken Zidovudine for a Long Time (NCT00001002) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Vitamin B Therapy for Hyperlactatemia (NCT00031057) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Zidovudine in HIV-Infected Patients Who Have Hemophilia (NCT00001104) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Previously Treated for PCP (NCT00000998) | National Institute of Allergy and Infectious Diseases (NIAID) | |